The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,2-Dimethyl-propionic acid 1-[2-(pyridin-2-ylmethanesulfinyl)-benzoimidazol-1-yl]-ethyl ester ID: ALA10186
PubChem CID: 14894179
Max Phase: Preclinical
Molecular Formula: C20H23N3O3S
Molecular Weight: 385.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(OC(=O)C(C)(C)C)n1c([S+]([O-])Cc2ccccn2)nc2ccccc21
Standard InChI: InChI=1S/C20H23N3O3S/c1-14(26-18(24)20(2,3)4)23-17-11-6-5-10-16(17)22-19(23)27(25)13-15-9-7-8-12-21-15/h5-12,14H,13H2,1-4H3
Standard InChI Key: FSWZCSXRAFQNMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
5.1382 -3.3972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2218 -4.2253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8934 -3.0602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4169 -2.9874 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6104 -4.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0344 -4.3980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7777 -5.5921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4515 -3.6809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1663 -6.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6951 -3.4012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3408 -6.9629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4123 -2.1559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3732 -5.8927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2614 -3.4057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9760 -2.9877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8173 -4.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4597 -5.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2793 -3.6742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1271 -7.2074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7222 -7.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0778 -6.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5443 -2.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9843 -2.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2875 -5.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6973 -4.3887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5449 -2.1650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2652 -1.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 2 1 0
6 2 1 0
7 5 1 0
8 3 1 0
9 7 1 0
10 4 1 0
11 9 1 0
12 4 1 0
13 9 2 0
14 15 2 0
15 10 1 0
16 5 1 0
17 6 2 0
18 8 2 0
19 11 1 0
20 11 1 0
21 11 1 0
22 14 1 0
23 15 1 0
24 17 1 0
25 18 1 0
26 27 1 0
27 23 2 0
6 8 1 0
24 25 2 0
26 22 2 0
M CHG 2 4 1 12 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.49Molecular Weight (Monoisotopic): 385.1460AlogP: 3.85#Rotatable Bonds: 5Polar Surface Area: 80.07Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.36CX LogP: 3.84CX LogD: 3.84Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.49Np Likeness Score: -0.86
References 1. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ] 2. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ]